Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-14 9:18 pm Sale | 2025-06-30 | 13G | Stardust Power Inc. SDST | Armistice Capital, LLC | 443,525 4.990% | -9,076 (-2.01%) | Filing History |
| 2025-08-14 9:18 pm Purchase | 2025-06-30 | 13G | Bellicum Pharmaceuticals, Inc. BLCM | Armistice Capital, LLC | 2,675,610 9.540% | 2,675,610 (New Position) | Filing History |
| 2025-08-14 9:18 pm Sale | 2025-06-30 | 13G | Oxbridge Re Holdings Limited OXBR | Armistice Capital, LLC | 395,792 4.990% | -226,373 (-36.38%) | Filing History |
| 2025-08-14 9:17 pm Sale | 2025-06-30 | 13G | Mural Oncology plc MURA | Armistice Capital, LLC | 0 0.000% | -1,722,000 (Position Closed) | Filing History |
| 2025-08-14 9:15 pm Purchase | 2025-06-30 | 13G | MetaVia Inc. MTVA | Armistice Capital, LLC | 1,270,887 4.990% | 368,639 (+40.86%) | Filing History |
| 2025-08-14 9:14 pm Sale | 2025-06-30 | 13G | Medicus Pharma Ltd. Common Stock MDCX | Armistice Capital, LLC | 935,724 4.990% | -330,276 (-26.09%) | Filing History |
| 2025-08-14 9:13 pm Purchase | 2025-06-30 | 13G | Bicycle Therapeutics plc BCYC | Armistice Capital, LLC | 2,284,381 9.990% | 2,284,381 (New Position) | Filing History |
| 2025-08-14 9:13 pm Purchase | 2025-06-30 | 13G | Moleculin Biotech, Inc. MBRX | Armistice Capital, LLC | 1,586,521 4.990% | 336,521 (+26.92%) | Filing History |
| 2025-08-14 9:12 pm Sale | 2025-06-30 | 13G | Kairos Pharma, Ltd. KAPA | Armistice Capital, LLC | 884,938 4.990% | -811,986 (-47.85%) | Filing History |
| 2025-08-14 9:11 pm Purchase | 2025-06-30 | 13G | Intensity Therapeutics, Inc. INTS | Armistice Capital, LLC | 1,237,113 2.560% | 364,566 (+41.78%) | Filing History |
| 2025-08-14 9:09 pm Purchase | 2025-06-30 | 13G | SeaStar Medical Holding Corporation ICU | Armistice Capital, LLC | 1,466,096 4.990% | 446,138 (+43.74%) | Filing History |
| 2025-08-14 9:08 pm Purchase | 2025-06-30 | 13G | Solana Company HSDT | Armistice Capital, LLC | 180,028 4.990% | 180,028 (New Position) | Filing History |
| 2025-08-14 9:08 pm Purchase | 2025-06-30 | 13G | Sphere 3D Corp. ANY | Armistice Capital, LLC | 672,134 9.990% | 672,134 (New Position) | Filing History |
| 2025-08-14 9:06 pm Sale | 2025-06-30 | 13G | Cosmos Health Inc. COSM | Armistice Capital, LLC | 1,582,313 4.990% | -335,397 (-17.49%) | Filing History |
| 2025-08-14 9:05 pm Purchase | 2025-06-30 | 13G | Calidi Biotherapeutics, Inc. CLDI | Armistice Capital, LLC | 117,368 4.990% | 117,368 (New Position) | Filing History |
| 2025-08-14 9:03 pm Purchase | 2025-06-30 | 13G | Enlivex Therapeutics Ltd. ENLV | Armistice Capital, LLC | 209,340 4.990% | 209,340 (New Position) | Filing History |
| 2025-08-14 9:02 pm Purchase | 2025-06-30 | 13G | CERo Therapeutics Holdings, Inc. CERO | Armistice Capital, LLC | 63,308 4.990% | 63,308 (New Position) | Filing History |
| 2025-08-14 9:02 pm Purchase | 2025-06-30 | 13G | LM Funding America, Inc. LMFA | Armistice Capital, LLC | 4,312,354 8.790% | 4,312,354 (New Position) | Filing History |
| 2025-08-14 9:01 pm Sale | 2025-06-30 | 13G | Creative Medical Technology Holdings, Inc. CELZ | Armistice Capital, LLC | 135,531 4.990% | -12,469 (-8.43%) | Filing History |
| 2025-08-14 8:59 pm Purchase | 2025-06-30 | 13G | Cibus, Inc. CBUS | Armistice Capital, LLC | 2,540,536 4.990% | 592,536 (+30.42%) | Filing History |